|
1
|
Gili M, Ramirez G, Béjar L and López J: Is
cocaine-associated acute myocardial infarction the same as
myocardial infarction associated with recent cocaine consumption?
Response. Rev Esp Cardiol (Engl Ed). 67:965–966. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kidawa M, Chizyński K, Zielińska M,
Kasprzak JD and Krzeminska-Pakula M: Real-time 3D echocardiography
and tissue Doppler echocardiography in the assessment of right
ventricle systolic function in patients with right ventricular
myocardial infarction. Eur Heart J Cardiovasc Imaging.
14:1002–1009. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kolte D, Khera S, Aronow WS, Mujib M,
Palaniswamy C, Sule S, Jain D, Gotsis W, Ahmed A, Frishman WH and
Fonarow GC: Trends in incidence, management, and outcomes of
cardiogenic shock complicating ST-elevation myocardial infarction
in the United States. J Am Heart Assoc. 3:e0005902014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sondergaard CS, Hess DA, Maxwell DJ,
Weinheimer C, Rosová I, Creer MH, Piwnica-Worms D, Kovacs A,
Pedersen L and Nolta JA: Human cord blood progenitors with high
aldehyde dehydrogenase activity improve vascular density in a model
of acute myocardial infarction. J Transl Med. 8:242010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malik MA, Khan Alam S, Safdar S and Taseer
IU: Chest Pain as a presenting complaint in patients with acute
myocardial infarction (AMI). Pak J Med Sci. 29:565–568. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dzeshka MS and Lip GY: Warfarin versus
dabigatran etexilate: An assessment of efficacy and safety in
patients with atrial fibrillation. Expert Opin Drug Saf. 14:45–62.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grottke O, van Ryn J, Spronk HM and
Rossaint R: Prothrombin complex concentrates and a specific
antidote to dabigatran are effective ex-vivo in reversing the
effects of dabigatran in an anticoagulation/liver trauma
experimental model. Crit Care. 18:R272014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanabria C, Cabrejos J, Olortegui A,
Guevara C and Lecca Garrido S: Costo-efectividad De apixaban con
otros noacs (Dabigatran Y Rivaroxaban) En El tratamiento De La
fibrilacion auricular no valvular (Fanv) En pacientes De La
seguridad social De Perú. Value Health. 18:A8292015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hajiri Mohd M, Shaharuddin S, Long CM,
Hashim R, Zulkifly HH, Kasim SS and Lim CW: Preliminary study of
safety and efficacy of warfarin versus dabigatran in atrial
fibrillation patients in a tertiary hospital in Malaysia. Value
Health. 18:A3782015. View Article : Google Scholar
|
|
10
|
de Boer JD, Berkhout LC, de Stoppelaar SF,
Yang J, Ottenhoff R, Meijers JC, Roelofs JJ, van't Veer C and van
der Poll T: Effect of the oral thrombin inhibitor dabigatran on
allergic lung inflammation induced by repeated house dust mite
administration in mice. Am J Physiol Lung Cell Mol Physiol.
309:L768–L775. 2015.PubMed/NCBI
|
|
11
|
Feistritzer HJ, Klug G, Reinstadler SJ,
Mair J, Seidner B, Mayr A, Franz WM and Metzler B: Aortic stiffness
is associated with elevated high-sensitivity cardiac troponin T
concentrations at a chronic stage after ST-segment elevation
myocardial infarction. J Hypertens. 33:1970–1976. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lax A, Sanchez-Mas J, Asensio-Lopez MC,
Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor-Perez FJ,
Januzzi JL and Pascual-Figal DA: Mineralocorticoid receptor
antagonists modulate galectin-3 and interleukin-33/ST2 signaling in
left ventricular systolic dysfunction after acute myocardial
infarction. JACC Heart Fail. 3:50–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Studer M, Zuber M, Jamshidi P, Buser P and
Erne P: Thromboembolic acute myocardial infarction in a congenital
double chambered left ventricle. Indian Heart J. 63:289–290.
2011.PubMed/NCBI
|
|
14
|
Seropian IM, Cerliani JP, Toldo S, Van
Tassell BW, Ilarregui JM, González GE, Matoso M, Salloum FN,
Melchior R, Gelpi RJ, et al: Galectin-1 controls cardiac
inflammation and ventricular remodeling during acute myocardial
infarction. Am J Pathol. 182:29–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brener SJ, Cristea E, Kirtane AJ,
McEntegart MB, Xu K, Mehran R and Stone GW: Intra-procedural stent
thrombosis: A new risk factor for adverse outcomes in patients
undergoing percutaneous coronary intervention for acute coronary
syndromes. JACC Cardiovasc Interv. 6:36–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Exaire JE, Fathi RB, Brener SJ, Karha J,
Ellis SG and Bhatt DL: Impaired myocardial perfusion score and
inflammatory markers in patients undergoing primary angioplasty for
acute myocardial infarction. Arch Cardiol Mex. 76:376–382.
2006.PubMed/NCBI
|
|
17
|
Hiroi T, Wajima T, Negoro T, Ishii M,
Nakano Y, Kiuchi Y, Mori Y and Shimizu S: Neutrophil TRPM2 channels
are implicated in the exacerbation of myocardial
ischaemia/reperfusion injury. Cardiovasc Res. 97:271–281. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mohseni M, Vafa M, Zarrati M, Shidfar F,
Hajimiresmail SJ and Forushani Rahimi A: Beneficial effects of
coenzyme Q10 supplementation on lipid profile and intereukin-6 and
intercellular adhesion molecule-1 reduction, preliminary results of
a double-blind trial in acute myocardial infarction. Int J Prev
Med. 6:732015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu W, Tang Y, Zhang Z, Zhang X, Yao Y, Fu
C, Wang X and Ma G: Inhibiting the mobilization of Ly6C(high)
monocytes after acute myocardial infarction enhances the efficiency
of mesenchymal stromal cell transplantation and curbs myocardial
remodeling. Am J Transl Res. 7:587–597. 2015.PubMed/NCBI
|
|
20
|
Kretzschmar D, Betge S, Windisch A,
Pistulli R, Rohm I, Fritzenwanger M, Jung C, Schubert K, Theis B,
Petersen I, et al: Recruitment of circulating dendritic cell
precursors into the infarcted myocardium and pro-inflammatory
response in acute myocardial infarction. Clin Sci (Lond).
123:387–398. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rodriguez AE, Fernandez M, Santaera O,
Larribau M, Bernardi V, Castaño H and Palacios LF: Coronary
stenting in patients undergoing percutaneous transluminal coronary
angioplasty during acute myocardial infarction. Am J Cardiol.
77:685–689. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aygül N, Aygül MU, Ozdemir K and
Altunkeser BB: Emergency revascularization procedures in patients
with acute ST-elevation myocardial infarction due to acute total
occlusion of unprotected left main coronary artery: A report of
five cases. Turk Kardiyol Dern Ars. 38:131–134. 2010.PubMed/NCBI
|
|
23
|
Ahmed RP, Haider KH, Shujia J, Afzal MR
and Ashraf M: Sonic Hedgehog gene delivery to the rodent heart
promotes angiogenesis via iNOS/netrin-1/PKC pathway. PLoS One.
5:e85762010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ribeiro DA, Buttros JB, Oshima CT,
Bergamaschi CT and Campos RR: Ascorbic acid prevents acute
myocardial infarction induced by isoproterenol in rats: Role of
inducible nitric oxide synthase production. J Mol Histol.
40:99–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bogatkevich GS, Ludwicka-Bradley A and
Silver RM: Dabigatran, a direct thrombin inhibitor, demonstrates
antifibrotic effects on lung fibroblasts. Arthritis Rheum.
60:3455–3464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bogatkevich GS, Ludwicka-Bradley A,
Nietert PJ, Akter T, van Ryn J and Silver RM: Antiinflammatory and
antifibrotic effects of the oral direct thrombin inhibitor
dabigatran etexilate in a murine model of interstitial lung
disease. Arthritis Rheum. 63:1416–1425. 2011. View Article : Google Scholar : PubMed/NCBI
|
